Efficacy of Different Neoadjuvant Therapies for Patients with Stage Ib2 and IIa2 Cervical Cancer
نویسندگان
چکیده
Cervical cancer (CC) is the third most commonly diagnosed cancer and the fourth leading cause of cancer death in females worldwide, and more than 85% of new cancer cases and deaths occur in developing countries, including in China (Jemal et al., 2011). As early stage tumor, stage Ib2 and IIa2 cervical cancer is a high-risk cancer with easy recurrence and metastasis, its 5-year survival rate is as low as about 50%, and is mainly treated with surgery combined neoadjuvant therapy (Zhao et al., 2012). This study aims to find the best neoadjuvant
منابع مشابه
The Comparison of Four Different Treatment Modalities in Bulky Stage Ib and Iia Cervix Cancers
Objective: To compare the effectiveness of four different treatment modalities in International Federation of Gynecology and Obstetrics (FIGO) IB2 and IIA2 bulky cervical cancers. Material and methods: Totally, n = 70 eligible women with bulky (≥4 cm) FIGO IB2 IIA2 cervical cancer that diagnosed and treated at our clinic between the years of 1/1994 1/2010 were reviewed retrospectively. Data reg...
متن کاملValues of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer.
OBJECTIVE To compare the clinical efficacy of concurrent chemoradiotherapy, neoadjuvant chemotherapy, and intracavity brachytherapy in comprehensive treatment for young patients with stage Ib2 cervical cancer. METHODS One hundred and twelve young patients with stage Ib2 cervical cancer were enrolled retrospectively in our hospital from January 2003 to June 2005. They were categorized into thr...
متن کاملSquamous cell carcinoma antigen expression in tumor cells is associated with the chemosensitivity and survival of patients with cervical cancer receiving docetaxel-carboplatin-based neoadjuvant chemotherapy
The present study examined the association between squamous cell carcinoma antigen (SCCA) expression and the response of patients with cervical cancer to docetaxel-carboplatin (DC) combination chemotherapy, in order to determine the prognostic potential of SCCA expression. A total of 21 patients were enrolled with stage IB2 or stage IIA2 SCC. Of these, 9 patients had chemotherapy-sensitive canc...
متن کاملNEOADJUVANT CHEMOTHERAPY WITH VINCRISTINE AND CISPLATIN FOLLOWED BY RADICAL HYSTERECTOMY AND PELVIC LYMPH ADENECTOMY FOR FIGO STAGE IB BULKY CERVICAL CANCER
Twenty patients with bulky (>4 cm size) FIGO stage IB cervical cancer were treated with cisplatin 50 mg/m2 and vincristine 1 mg/m2, administered intravenously at 10-day intervals for a total of 3 courses before radical hysterectomy. A complete clinical response was noted in 1 patient (5%) and partial response in 5 (25%). Fourteen patients (70%) had stable disease. There was no grade 3 toxic...
متن کاملCOMPARATIVE STUDY OF CHEMORADIATION AND NEOADJUV ANT CHEMOTHERAPY BEFORE RADICAL HYSTERECTOMY IN STAGE m - 1m BULKY CERVICAL CANCER AND WITH TUMOR DIAMETER GREATER THAN 4 CM
Tumor size seems to be a determinant in the prognosis of early cervical cancer. Patients with tumor size greater than 4 cm (bulky) in diameter have worse outcome.' The purpose of this study was to compare the efficacy of preoperative combined chemoradiation and neoadjuvant chemotherapy (NArC) programs followed by radical hysterectomy in stage Ib - lIb bulky cervical cancer. From September ...
متن کامل